Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes
- PMID: 30656531
- PMCID: PMC6449307
- DOI: 10.1007/s11060-019-03104-3
Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes
Erratum in
-
Correction to: Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes.J Neurooncol. 2019 Sep;144(2):427-429. doi: 10.1007/s11060-019-03237-5. J Neurooncol. 2019. PMID: 31368055 Free PMC article.
Abstract
Background: Incidental discovery accounts for 30% of newly-diagnosed intracranial meningiomas. There is no consensus on their optimal management. This review aimed to evaluate the outcomes of different management strategies for these tumors.
Methods: Using established systematic review methods, six databases were scanned up to September 2017. Pooled event proportions were estimated using a random effects model. Meta-regression of prognostic factors was performed using individual patient data.
Results: Twenty studies (2130 patients) were included. Initial management strategies at diagnosis were: surgery (27.3%), stereotactic radiosurgery (22.0%) and active monitoring (50.7%) with a weighted mean follow-up of 49.5 months (SD = 29.3). The definition of meningioma growth and monitoring regimens varied widely impeding relevant meta-analysis. The pooled risk of symptom development in patients actively monitored was 8.1% (95% CI 2.7-16.1). Associated factors were peritumoral edema (OR 8.72 [95% CI 0.35-14.90]) and meningioma diameter ≥ 3 cm (OR 34.90 [95% CI 5.17-160.40]). The pooled proportion of intervention after a duration of active monitoring was 24.8% (95% CI 7.5-48.0). Weighted mean time-to-intervention was 24.8 months (SD = 18.2). The pooled risks of morbidity following surgery and radiosurgery, accounting for cross-over, were 11.8% (95% CI 3.7-23.5) and 32.0% (95% CI 10.6-70.5) respectively. The pooled proportion of operated meningioma being WHO grade I was 94.0% (95% CI 88.2-97.9).
Conclusion: The management of incidental meningioma varies widely. Most patients who clinically or radiologically progressed did so within 5 years of diagnosis. Intervention at diagnosis may lead to unnecessary overtreatment. Prospective data is needed to develop a risk calculator to better inform management strategies.
Keywords: Asymptomatic; Incidental; Meningioma; Meta-analysis; Systematic review.
Conflict of interest statement
A.I.I., M.M., R.D.C.M., N.S., S.J.M., A.R.B. and M.D.J. have no relevant financial relationships or conflicts of interest to disclose.
Figures
Similar articles
-
A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas.Neuro Oncol. 2020 Feb 20;22(2):278-289. doi: 10.1093/neuonc/noz160. Neuro Oncol. 2020. PMID: 31603516 Free PMC article.
-
Incidental meningiomas.Neurosurg Focus. 2011 Dec;31(6):E19. doi: 10.3171/2011.9.FOCUS11220. Neurosurg Focus. 2011. PMID: 22133182 Review.
-
Overview and recent advances in incidental meningioma.Expert Rev Anticancer Ther. 2023 Apr;23(4):397-406. doi: 10.1080/14737140.2023.2193333. Epub 2023 Mar 27. Expert Rev Anticancer Ther. 2023. PMID: 36951191 Review.
-
Treatment Outcomes of Incidental Intracranial Meningiomas: Results from the IMPACT Cohort.World Neurosurg. 2020 Jun;138:e725-e735. doi: 10.1016/j.wneu.2020.03.060. Epub 2020 Mar 19. World Neurosurg. 2020. PMID: 32200011
-
Recurrence of intracranial meningiomas: did better methods of diagnosis and surgical treatment change the outcome in the last 30 years?Neurol Res. 2009 Jun;31(5):478-82. doi: 10.1179/174313208X338043. Epub 2009 Jun 4. Neurol Res. 2009. PMID: 19500450
Cited by
-
An international multicenter matched cohort analysis of incidental meningioma progression during active surveillance or after stereotactic radiosurgery: the IMPASSE study.Neuro Oncol. 2022 Jan 5;24(1):116-124. doi: 10.1093/neuonc/noab132. Neuro Oncol. 2022. PMID: 34106275 Free PMC article.
-
A semi-automatic segmentation method for meningioma developed using a variational approach model.Neuroradiol J. 2024 Apr;37(2):199-205. doi: 10.1177/19714009231224442. Epub 2023 Dec 26. Neuroradiol J. 2024. PMID: 38146866 Free PMC article.
-
How should we manage incidental meningiomas?Neuro Oncol. 2020 Feb 20;22(2):173-174. doi: 10.1093/neuonc/noz237. Neuro Oncol. 2020. PMID: 31875227 Free PMC article. No abstract available.
-
Cranial meningioma with bone involvement: surgical strategies and clinical considerations.Acta Neurochir (Wien). 2023 May;165(5):1355-1363. doi: 10.1007/s00701-023-05535-4. Epub 2023 Mar 6. Acta Neurochir (Wien). 2023. PMID: 36877330 Free PMC article.
-
Meningioma and Other Meningeal Tumors.Adv Exp Med Biol. 2023;1405:73-97. doi: 10.1007/978-3-031-23705-8_3. Adv Exp Med Biol. 2023. PMID: 37452935
References
-
- Hayward R. VOMIT (victims of modern imaging technology)—an acronym for our times. BMJ. 2003;326:1273. doi: 10.1136/bmj.326.7401.1273. - DOI
-
- Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M, Moyal EC, Brandsma D, Henriksson R, Soffietti R, Weller M. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol. 2016;17:e383–e391. doi: 10.1016/S1470-2045(16)30321-7. - DOI - PubMed
-
- de Boer AW, Drewes YM, de Mutsert R, Numans ME, den Heijer M, Dekkers OM, de Roos A, Lamb HJ, Blom JW, Reis R. Incidental findings in research: A focus group study about the perspective of the research participant. J Magn Reson Imaging. 2017 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources